Teresa Gisinger on Sex Hormones and Cardiovascular Risk in Type 2 DM
Teresa Gisinger, Researcher (Doctoral Candidate) at Medical University of Vienna, shared on LinkedIn:
”I’m excited to share our newly published study
We found that in older men with type 2 diabetes, baseline testosterone and changes in estradiol and SHBG after lifestyle intervention are associated with long-term cardiovascular risk, whereas no comparable link was found in postmenopausal women”
Read the full article here.
Article: Sex Hormones and Cardiovascular Risk in Type 2 Diabetes: Cohort Study of the LookAHEAD Trial
Authors: Teresa Gisinger, Jiahuan Helen He, Chigolum P. Oyeka, Jianqiao Ma, Nityasree Srialluri, Mark Woodward, Erin D. Michos, Rita R. Kalyani, Jeanne M. Clark, Alexandra Kautzky-Willer, Dhananjay Vaidya, Wendy L. Bennett
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight
-
Aug 14, 2026, 18:20Venkata Sagi: Systemic Anticoagulation or Left Atrial Appendage Closure?
-
Aug 14, 2026, 18:02Marios Psychogios: Every Minute Matters in Acute Stroke Care
-
Aug 14, 2026, 17:57Molly Lippold-Meinholz: The Magic of Camp for Kids With Bleeding Disorders
-
Aug 14, 2026, 17:52Will Thomas: Why Dose Every Missed Thromboprophylaxis Matter
-
Aug 14, 2026, 17:42Nandini Pethe: Representing MicroHealth at BDC
-
Aug 14, 2026, 17:30Richard Habis: Hemophilia Does Not Only Affect the Child
-
Aug 14, 2026, 17:00Zahra Safarzadeh: The Critical Role of the Laboratory in Hemophilia Care
-
Aug 14, 2026, 16:39Yuriy Prokopenko: Advancing Hemostasis Through Scientific Collaboration